Article View: be.science
Article #402Cancer - Press review (August 13, 2011) – Revue de presse (13 août 2011)
From: SciMedWeb
Date: Sat, 13 Aug 2011 08:22
Date: Sat, 13 Aug 2011 08:22
147 lines
6967 bytes
6967 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press review (August 13, 2011) – Revue de presse (13 août 2011) 'Serial Killer' Immune Cells Put Cancer in Remission The cancer therapy, described today in two papers in Science Translational Medicine and The New England Journal of Medicine, is based on the idea that the human body is already primed to fight abnormal, dangerous cells. T cells, frontline defenders of the immune system, recognize cells that don't belong in the body—such as bacteria— and set off a cascade of events to kill them. By Sarah C.P. Williams. In Science AAAS http://news.sciencemag.org/sciencenow/2011/08/serial-killer-immune-cells-put-c.html?ref=hp Music soothes cancer patients In the most comprehensive international review yet, a team of scientists has found listening to music can reduce pain, lower blood pressure and heart rates in cancer patients. By Sarah Dingle. In ABC Online http://www.abc.net.au/news/2011-08-11/music-soothes-cancer-patients/2834708r Insomnia, sleep problems common in cancer patients More than half of cancer patients may suffer insomnia during treatment -- and for some, sleep problems can persist for months afterward, according to a study. By Elaine Lies. Reuters http://www.reuters.com/article/2011/08/11/health-insomnia-cancer-idUSL3E7JB0BT20110811 Breast cancer drug raises risk of heart problems in older women The breast cancer drug Herceptin (trastuzumab) increases the risk of heart problems in elderly patients, especially those with a history of heart disease and/or diabetes, a new study says. In USA Today http://yourlife.usatoday.com/health/medical/breastcancer/story/2011/08/Breast-cancer-drug-raises-risk-of-heart-problems-in-oder-women/49910178/1?csp=34news Morning smokers may be at higher cancer risk Smokers who light up right after they wake up in the morning may be at greater risk for lung, head and neck cancers than those who wait longer before having their first cigarette of the day, a new study finds. By Mary Elizabeth Dallas. In USA Today http://yourlife.usatoday.com/health/story/2011/08/Morning-smokers-may-be-at-higher-cancer-risk/49883834/1 More aggressive chemo better for older lung cancer patients Fit older lung cancer patients would be better treated with a more aggressive form of chemotherapy than they are commonly given, a study indicates. By Stephen Adams. In Telegraph.co.uk http://www.telegraph.co.uk/health/8688840/More-aggressive-chemo-better-for-older-lung-cancer-patients.html Ovarian cancer risk gene pinpointed 'Incredibly exciting' find implicates defect in RAD51D gene as hugely increasing the chances of developing ovarian cancer. By Alok Jha. In The Guardian http://www.guardian.co.uk/science/2011/aug/08/ovarian-cancer-gene Hot Chemotherapy Bath: Patients See Hope, Critics Hold Doubts This is cancer therapy at its most aggressive, a treatment patients liken to being filleted, disemboweled and then bathed in hot poison. By Andrew Pollack. In The New-York Times http://www.nytimes.com/2011/08/12/business/heated-chemotherapy-bath-may-be-only-hope-for-some-cancer-patients.html Dual-action protein better restricts blood vessel formation Cancer needs blood. In fact, some cancer medications work solely to slow or prevent cancer cells from creating new capillaries, choking off their much-needed blood and nutrient supply to halt the growth of tumors. In Science Daily (press release) http://www.sciencedaily.com/releases/2011/08/110811162839.htm Cancer : la première cigarette est la plus meurtrière Les fumeurs qui consomment rapidement après leur réveil s'exposeraient plus que les autres à certains cancers. Par Jean-David Raynal. Dans Le Point http://www.lepoint.fr/sante/cancer-la-premiere-cigarette-est-la-plus-meurtriere-10-08-2011-1361381_40.php Un traitement expérimental encourageant contre la leucémie la plus courante Une équipe de recherche de Pennsylvanie a mis au point un nouveau traitement expérimental contre la leucémie lymphoïde chronique, forme la plus courante du cancer du sang. MaxiSciences http://www.maxisciences.com/leuc%E9mie/un-traitement-experimental-encourageant-contre-la-leucemie-la-plus-courante_art16294.html Bruxelles: un institut pour étudier les cancers liés à l'environnement est né A Bruxelles, un nouvel organisme scientifique a vu le jour: l'Institut de recherche européen sur le cancer et l'environnement. Son objectif est d’analyser les cancers liés à l’environnement. Par Pierre Vandenbulcke & Delphine Wilputte. RTBF http://www.rtbf.be/info/regions/detail_bruxelles-un-institut-pour-etudier-les-cancers-lies-a-l-environnement-est-ne?id=6566253 Fumer la pipe à eau est particulièrement dangereux en Suisse En Suisse, le taux d'agents humectants dans le tabac à narguilé est bien plus élevé qu'ailleurs, ce qui accroît fortement les risques de cancer. In Le Matin Online http://www.lematin.ch/actu/suisse/fumer-la-pipe-eaux-est-particulierement-dangereux-en-suisse Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix – Oncowal & Wallogene (08/2011)
Technical Details
Message-ID:
<5d512f17-6c03-4698-91f5-f1e3f4abe6ef@u15g2000yqi.googlegroups.com>Path:
arc1-ca.pugleaf.net!g2news2.google.com!postnews.google.com!u15g2000yqi.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: f5500,8c5c6ce9bb6e470e,start X-Google-NewGroupId: yes X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet X-Google-Language: ENGLISH,UTF8 Path: arc1-ca.pugleaf.net!g2news2.google.com!postnews.google.com!u15g2000yqi.googlegroups.com!not-for-mail From: SciMedWeb <scimedweb@mail.com> Newsgroups: be.science Subject: Cancer - Press review (August 13, 2011) – Revue de presse (13 août 2011) Date: Sat, 13 Aug 2011 01:22:15 -0700 (PDT) Organization: http://groups.google.com Lines: 147 Message-ID: <5d512f17-6c03-4698-91f5-f1e3f4abe6ef@u15g2000yqi.googlegroups.com> NNTP-Posting-Host: 87.65.250.28 Mime-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: quoted-printable X-Trace: posting.google.com 1313223736 28031 127.0.0.1 (13 Aug 2011 08:22:16 GMT) X-Complaints-To: groups-abuse@google.com NNTP-Posting-Date: Sat, 13 Aug 2011 08:22:16 +0000 (UTC) Complaints-To: groups-abuse@google.com Injection-Info: u15g2000yqi.googlegroups.com; posting-host=87.65.250.28; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE User-Agent: G2/1.0 X-Google-Web-Client: true X-Google-Header-Order: UHALERCNK X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.8.131 Version/11.11,gzip(gfe)